HIPO - Hippo Holdings Inc.
NYSE
->
Financial Services
->
Insurance—Specialty
Palo Alto,
United States
Type: Equity
HIPO price evolution
HIPO
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $76 | $86.9 | $120.2 | $54.3 |
| Short term investments | ||||
| Net receivables | $89 | $81.7 | $82.2 | $73.8 |
| Inventory | ||||
| Total current assets | $89 | $81.7 | $82.2 | $73.8 |
| Long term investments | ||||
| Property, plant & equipment | ||||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1545.4 | $1510.3 | $1496.3 | $1524.7 |
| Current liabilities | ||||
| Accounts payable | ||||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $43.3 | $49.8 | $51.7 | $54.4 |
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1219 | $1187.7 | $1145.1 | $1146.8 |
| Shareholders' equity | ||||
| Retained earnings | -$1319.2 | -$1310.6 | -$1270.1 | -$1234.4 |
| Other shareholder equity | $0.5 | -$3.6 | -$3.4 | -$2.9 |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $54.3 | $65.7 | $219.2 | $56.7 |
| Short term investments | ||||
| Net receivables | $73.8 | $45.8 | $41.6 | $21.3 |
| Inventory | ||||
| Total current assets | $73.8 | $45.8 | $41.6 | $1.7 |
| Long term investments | ||||
| Property, plant & equipment | $0.9 | |||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1524.7 | $1568.9 | $1642.7 | $979.4 |
| Current liabilities | ||||
| Accounts payable | $0.5 | |||
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $54.4 | $81.3 | $41.2 | $0.15 |
| Long term debt | $273 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1146.8 | $979 | $783.1 | $834.2 |
| Shareholders' equity | ||||
| Retained earnings | -$1234.4 | -$961.1 | -$628 | -$256.6 |
| Other shareholder equity | -$2.9 | -$7 | -$0.76 | $0.04 |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $95.5 | $89.6 | $85.1 | $64.5 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $109 | $126 | $114.4 | $99.3 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.7 | $0.2 | $0.3 | |
| Interest expense | $0.1 | -$0.1 | $1.3 | |
| Net income | ||||
| Net income | -$8.5 | -$40.5 | -$35.7 | -$42.3 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $209.7 | $119.7 | $91.2 | $51.6 |
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $467.5 | $392.1 | $306.5 | $168.8 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $0.5 | $1.3 | $0.7 | -$1.8 |
| Interest expense | $0.8 | $2.5 | -$198.9 | -$26 |
| Net income | ||||
| Net income | -$273.1 | -$333.4 | -$371.4 | -$141.5 |
| Income (for common shares) | ||||
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $2.5 | $30.4 | $58.5 | $57.6 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$20.6 | -$12.4 | -$8 | -$14.6 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $35.8 | $25.1 | $68.2 | -$49.4 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2021 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $57.6 | -$405.9 | -$30 | -$2.3 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$14.6 | -$6.8 | $480.8 | $518.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$49.4 | -$574.2 | $326.3 | $450.4 |
News
Fundamentals
| Market cap | $768.32M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 25.23M |
| Revenue | $334.70M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$127.00M |
| Revenue Q/Q | 211.07% |
| Revenue Y/Y | N/A |
| P/E ratio | -6.05 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 2.30 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 3.01 |
| EPS | -$5.03 |
|---|---|
| ROA | -8.36% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.06 |
| Quick ratio | N/A |